These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5132588)

  • 1. LSD: its effect upon 5-hydroxytryptamine in embryonic development of Xenopus laevis.
    Baker PC
    Experientia; 1971 May; 27(5):536-7. PubMed ID: 5132588
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA
    Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine).
    Lin RC; Ngai SH; Costa E
    Science; 1969 Oct; 166(3902):237-9. PubMed ID: 5809595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the secretion of intermedine by D-lysergic acid diethylamide (LSD 25) in the toad, Xenopus laevis.
    BURGERS AC; LEEMREIS W; DOMINIC ZAK T; VAN OORDT GJ
    Acta Endocrinol (Copenh); 1958 Oct; 29(2):191-200. PubMed ID: 13605504
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].
    Kohút A; Nicák A
    Bratisl Lek Listy; 1977 Sep; 68(3):336-43. PubMed ID: 912454
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonergic and dopaminergic influence of the duration of embryogenesis and intracapsular locomotion of Lymnaea stagnalis L.
    Filla A; Hiripi L; Elekes K
    Acta Biol Hung; 2004; 55(1-4):315-21. PubMed ID: 15270248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
    Ziegler MG; Lovell RA; Freedman DX
    Biochem Pharmacol; 1973 Sep; 22(17):2183-93. PubMed ID: 4270151
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of LSD on synthesis and release of 5-HT in rat brain slices.
    Hamon M; Bourgoin S; Jagger J; Glowinski J
    Brain Res; 1974 Apr; 69(2):265-80. PubMed ID: 4823095
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistent increase in brain serotonin turnover after chronic administration of LSD in the rat.
    Díaz JL; Huttunen MO
    Science; 1971 Oct; 174(4004):62-4. PubMed ID: 5120868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of LSD-25 on brain serotonin.
    FREEDMAN DX
    J Pharmacol Exp Ther; 1961 Nov; 134():160-6. PubMed ID: 13894866
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptosomal uptake and release of dopamine and 5-hydroxy-tryptamine in the nucleus accumbens in vitro following in vivo administration of lysergic acid diethylamide in rats.
    Hetey L; Quiring K
    Acta Biol Med Ger; 1980; 39(8-9):889-95. PubMed ID: 7282218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of LSD, BOL, and chlorpromazine on "neurohormone" metabolism.
    SIVA SANKAR DV; PHIPPS E; GOLD E; SANKAR DB
    Ann N Y Acad Sci; 1962 Jan; 96():93-7. PubMed ID: 13913509
    [No Abstract]   [Full Text] [Related]  

  • 16. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica.
    MANSOUR TE
    Br J Pharmacol Chemother; 1957 Dec; 12(4):406-9. PubMed ID: 13489165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling.
    Buchborn T; Schröder H; Höllt V; Grecksch G
    J Psychopharmacol; 2014 Jun; 28(6):545-52. PubMed ID: 24785760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent effects of repeated injections of D-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels.
    Peters DA; Tang S
    Biochem Pharmacol; 1977 Jun; 26(11):1085-6. PubMed ID: 880261
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of 5-hydroxytryptamine and d-lysergic acid diethylamide in the transcallosal response.
    Bond HW; Guth PS
    Life Sci; 1968 Mar; 7(5):249-58. PubMed ID: 5641717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.